Share Prices & Company Research

Stockbroking

Oxford Biomedica Plc

Current Price 300.50p Bid 293.50p Ask 307.50p Change 2.39%
Last Updated: 17/05/2025 17:08. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Financial Highlights Year Ended 31/12/2024

Revenue
£128.80m
Operating Profit/Loss
£-39.38m
Dividend yield (%)
n/a
Total dividend for year
n/ap
Dividend cover
n/a
P/E Ratio
n/a

Key Personnel

Dr Frank Mathias
Chief Executive Officer
Mr Lucinda (Lucy) Crabtree
Chief Financial Officer
Mr Stuart Henderson
Deputy Chairman
Dr Heather Preston
Independent Non-Executive Director
Ms Namrata P Patel
Independent Non-Executive Director
Dr Roch Doliveux
Non-Executive Chairman
Mr Colin Bond
Non-Executive Director
Mr Dame Kay Davies
Non-Executive Director
Mr Peter Soelkner
Non-Executive Director
Mr Robert Ghenchev
Non-Executive Director
Ms Laurence Espinasse
Non-Executive Director

Stock Details

EPIC
OXBL
ISIN
GB0006648157
Shares in Issue
0.00m
Market cap
£0.00m

Price Summary

Mid Price
300.50p
Bid Price
293.50p
Ask Price
307.50p
Volume
4,606
Change Today
7.00p
% Change Today
2.39%
Open
298.50p
Previous Close
300.50p
Intraday High
300.50p
Intraday Low
295.00p
52 Week High
444.50p
52 Week Low
235.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.